CN103330831B - Traditional Chinese medicine for treating purple plague - Google Patents

Traditional Chinese medicine for treating purple plague Download PDF

Info

Publication number
CN103330831B
CN103330831B CN201310201256.4A CN201310201256A CN103330831B CN 103330831 B CN103330831 B CN 103330831B CN 201310201256 A CN201310201256 A CN 201310201256A CN 103330831 B CN103330831 B CN 103330831B
Authority
CN
China
Prior art keywords
parts
chinese medicine
traditional chinese
purple plague
radix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201310201256.4A
Other languages
Chinese (zh)
Other versions
CN103330831A (en
Inventor
陈松
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yan Jun
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201310201256.4A priority Critical patent/CN103330831B/en
Publication of CN103330831A publication Critical patent/CN103330831A/en
Application granted granted Critical
Publication of CN103330831B publication Critical patent/CN103330831B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a traditional Chinese medicine for treating purple plague. The traditional Chinese medicine comprises, by weight, 2 to 3 parts of ginseng, 5 to 8 parts of pseudo-ginseng, 1 to 2 parts of epimeddium, 10 to 12 parts of wolfberry, 10 to 12 parts of caltha palustris, 5 to 8 parts of esliptae herba, 6 to 9 parts of Chinese angelica, 10 to 12 parts of red sage root, 10 to 12 parts of gynostemma pentaphylla, 10 to 12 parts of lily, 6 to 9 parts of polygonatum odoratum, 6 to 9 parts of bighead atractylodes rhizome, 6 to 9 parts of Stellaria yunnanensis Franch., 10 to 12 parts of mango leaf, 5 to 8 parts of Phtheirospermum tenuisectum Bur. et Franch., 10 to 12 parts of root bark of the peony tree and 6 to 9 parts of cassia twig. The traditional Chinese medicine has effects of clearing heat and removing toxins, tonifying qi and intensifying the middle-jiao, enriching yin and nourishing kidney, cooling blood and dispersing blood stasis, and treating purple plague, avoids purple plague recurrence and has no toxic or side effect.

Description

A kind of Chinese medicine for the treatment of purpura
Technical field
the present invention relates to the field of Chinese medicines, be specifically related to a kind of Chinese medicine for the treatment of purpura.
Background technology
Purpura, is also referred to as hematohidrosis, and majority refers between blood from overflowing skin, the disease of the livid purple speckle of cutaneous manifestations or speckle.The caused subcutaneous purpura such as hematopathy, avitaminosis of doctor trained in Western medicine, all can refer to assertive evidence determination for the treatment of based on pathogenesis obtained through differentiation of symptoms and signs.Conventional western medicine, DeGrain, the existing treatment by Chinese herbs time is long, and curative effect is not obvious.
Summary of the invention
the invention discloses the Chinese medicine of a kind of purpura, this Chinese medicine have heat-clearing and toxic substances removing, QI invigorating build in, enriching yin and nourishing kidney, cooling blood and removing stasis effect, treatment purpura good effect, cure rate is high, does not recur after curing, without any side effects.
The technical solution used in the present invention is as follows:
Radix Ginseng 2-3, Radix Notoginseng 5-8, Herba Epimedii 1-2, Fructus Lycii 10-12, Herba Calthae 10-12, Herba Ecliptae 5-8, Radix Angelicae Sinensis 6-9, Radix Salviae Miltiorrhizae 10-12, Herb Gynostemmae Pentaphylli 10-12, Bulbus Lilii 10-12, Rhizoma Polygonati Odorati 6-9, Rhizoma Atractylodis Macrocephalae 6-9, Radix Stellariae Yunnanensis 6-9, Folium mangiferae 10-12, Phtheirospermum tenuisectum Bur.et Franch. 5-8, Cortex Moutan 10-12, Ramulus Cinnamomi 6-9.
Usage and consumption: take 1 dose day, decoct moisture and take for 2 to 3 times.Within 1 month, be a course for the treatment of, the lighter takes 1-4 the course for the treatment of, and purpura severe patient needs to take 6-10 the course for the treatment of.
beneficial effect:
During Effect of Chinese Medicine Qing thermal detoxification of the present invention, QI invigorating are built, enriching yin and nourishing kidney, cooling blood and removing stasis effect, treatment purpura good effect, does not recur after curing, without any side effects.
Detailed description of the invention
The Chinese medicine of a kind of purpura, be made up of following component, the weight portion (gram) of each component is: Radix Ginseng 2, Radix Notoginseng 8, Herba Epimedii 2, Fructus Lycii 10, Herba Calthae 12, Herba Ecliptae 8, Radix Angelicae Sinensis 6, Radix Salviae Miltiorrhizae 12, Herb Gynostemmae Pentaphylli 10, Bulbus Lilii 10, Rhizoma Polygonati Odorati 9, the Rhizoma Atractylodis Macrocephalae 9, Radix Stellariae Yunnanensis 6, Folium mangiferae 12, Phtheirospermum tenuisectum Bur.et Franch. 5, Cortex Moutan 10, Ramulus Cinnamomi 9.
Usage and consumption: take 1 dose day, decoct moisture and take for 2 to 3 times.Within 1 month, be a course for the treatment of, the lighter takes 1-4 the course for the treatment of, and purpura severe patient needs to take 6-10 the course for the treatment of.
model case
Wang, man, 12 years old,
Symptom: two being dispersed in property of lower limb purpura, unable, low grade fever sometimes, in examination in hospital platelet 38 × 10 9/ L, based on prednisone medicine, 2 wheat harvesting periods of taking medicine, platelet is all the time 40 × 10 9/ L is to 55 × 10 9between/L, leukocyte is 9 × 10 9/ L is to 14 × 10 9between/L, easy catching a cold, spirit is not good enough, moon face, light red tongue, and tongue is few, and pharynx is light congested, left volume submental lymph nodes Semen Pisi sativi size, mild tenderness.
Diagnosis: purpura.
Treatment: take Chinese medicine of the present invention, take 1 dose day, decoct moisture and take for 2 times.Take after two months, again check, platelet is 60 × 10 9/ L is to 90 × 10 9between/L, leukocyte returns to normal range substantially,
After continuing to take top half a year, reinspection is looked into, and platelet rises to 95 × 10 9/ L is to 140 × 10 9between/L, leukocyte returns to normal range.
Field, man, 9 years old,
Symptom: more than two being dispersed in property of lower limb purpura moon, easy catching a cold, spirit is not good enough, light red tongue, and tongue is few, and pharynx is light congested, left volume submental lymph nodes Semen Pisi sativi size, mild tenderness.
Diagnosis: purpura.
Treatment: take Chinese medicine of the present invention, take 1 dose day, decoct moisture and take for 2 times.After taking one month, again check, platelet is 70 × 10 9/ L is to 100 × 10 9between/L, leukocyte returns to normal range substantially,
After continuing to take half a year, reinspection is looked into, and platelet rises to 105 × 10 9/ L is to 140 × 10 9between/L, leukocyte returns to normal range.

Claims (1)

1. treat a Chinese medicine for purpura, it is characterized in that, be made up of following component, the weight portion of each component is:
Radix Ginseng 2-3, Radix Notoginseng 5-8, Herba Epimedii 1-2, Fructus Lycii 10-12, Herba Calthae 10-12, Herba Ecliptae 5-8, Radix Angelicae Sinensis 6-9, Radix Salviae Miltiorrhizae 10-12, Herb Gynostemmae Pentaphylli 10-12, Bulbus Lilii 10-12, Rhizoma Polygonati Odorati 6-9, Rhizoma Atractylodis Macrocephalae 6-9, Radix Stellariae Yunnanensis 6-9, Folium mangiferae 10-12, Phtheirospermum tenuisectum Bur.et Franch. 5-8, Cortex Moutan 10-12, Ramulus Cinnamomi 6-9.
CN201310201256.4A 2013-05-28 2013-05-28 Traditional Chinese medicine for treating purple plague Expired - Fee Related CN103330831B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310201256.4A CN103330831B (en) 2013-05-28 2013-05-28 Traditional Chinese medicine for treating purple plague

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310201256.4A CN103330831B (en) 2013-05-28 2013-05-28 Traditional Chinese medicine for treating purple plague

Publications (2)

Publication Number Publication Date
CN103330831A CN103330831A (en) 2013-10-02
CN103330831B true CN103330831B (en) 2015-03-25

Family

ID=49239081

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310201256.4A Expired - Fee Related CN103330831B (en) 2013-05-28 2013-05-28 Traditional Chinese medicine for treating purple plague

Country Status (1)

Country Link
CN (1) CN103330831B (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1238956C (en) * 2002-06-13 2006-01-25 台达电子工业股份有限公司 Flexible switching DC-DC converter with active energy discharging slot
CN103071068A (en) * 2013-01-22 2013-05-01 李承平 Cicada wind-dispelling and cooling tablet
CN102688302B (en) * 2012-05-09 2014-02-05 乔振国 Traditional Chinese medicine for treating dermatitis, allergic purpura, psoriasis and herpes zoster
CN102688421B (en) * 2012-05-08 2014-07-09 安徽智远生物科技有限公司 Traditional Chinese medicine for treating purpura and preparation process thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1238956A (en) * 1998-06-12 1999-12-22 许世平 Baixuekang for curing leukemia

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1238956C (en) * 2002-06-13 2006-01-25 台达电子工业股份有限公司 Flexible switching DC-DC converter with active energy discharging slot
CN102688421B (en) * 2012-05-08 2014-07-09 安徽智远生物科技有限公司 Traditional Chinese medicine for treating purpura and preparation process thereof
CN102688302B (en) * 2012-05-09 2014-02-05 乔振国 Traditional Chinese medicine for treating dermatitis, allergic purpura, psoriasis and herpes zoster
CN103071068A (en) * 2013-01-22 2013-05-01 李承平 Cicada wind-dispelling and cooling tablet

Also Published As

Publication number Publication date
CN103330831A (en) 2013-10-02

Similar Documents

Publication Publication Date Title
CN103784820A (en) Traditional Chinese medicine formula for treating cariac blood stasis type coronary heart disease
CN102302751B (en) Chinese medicine for treating migraine
CN102379968B (en) Traditional Chinese medicine composition for treating purpura
CN103393966B (en) A kind of Chinese medicine composition for the treatment of menoxenia
CN103432503A (en) Traditional Chinese medicine composition
CN101569730A (en) Traditional Chinese medicine tolnaftate
CN101695566A (en) Chinese medicament for treating cephalagra
CN102688447B (en) Traditional Chinese medicine for treating palpitation and cardiac pain, and preparation method thereof
CN101912540A (en) Medicament for treating cerebral infarction
CN103330831B (en) Traditional Chinese medicine for treating purple plague
CN104306876A (en) Traditional Chinese medicinal composition for treating anemopyretic cold
CN102688421B (en) Traditional Chinese medicine for treating purpura and preparation process thereof
CN102940734B (en) Traditional Chinese medicine for treating purpura
CN104288041A (en) Method for preparing skin care water for promoting sleep
CN101284117A (en) Stone-dissolving good prescription
CN103656492A (en) Traditional Chinese medicine for external use for treating headache
CN104069421A (en) Traditional Chinese medicine composition for treating heart diseases
CN103638287A (en) Chinese medicine composition for treating schizophrenia
CN102940766B (en) Traditional Chinese medicine for treating chronic nephritis
CN103768243A (en) Traditional Chinese medicine for treating female infertility
CN101658661A (en) Chinese medicinal composition having effect of promoting blood circulation and removing blood stasis
CN102451396A (en) Chinese medicinal formula for treating acute pyelonephritis
CN103736011A (en) Injection nursing medicine for lowering cholesterol and preparation method thereof
CN101297951A (en) Pellet for soothing nerve and releasing depression
CN104800391A (en) Traditional Chinese medicine for treating hepatitis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C41 Transfer of patent application or patent right or utility model
CB03 Change of inventor or designer information

Inventor after: Yan Jun

Inventor before: Chen Song

COR Change of bibliographic data
TR01 Transfer of patent right

Effective date of registration: 20170301

Address after: 247100 Chizhou City, Qingyang Province, Rong County, Anhui town Ridge Lane Lane, room 12, No. 103

Patentee after: Yan Jun

Address before: 233000 Anhui Province, Bengbu City Industrial Park, Huaishang District small Bengbu Street Health Center

Patentee before: Chen Song

CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20150325

Termination date: 20170528

CF01 Termination of patent right due to non-payment of annual fee